Figure 7: β3-AR agonism reduces dyslipidemia in E3L mice in the absence of CETP.
From: Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development
E3L mice were fed a WTD and treated with vehicle or the β3-AR agonist CL316243. Fasted plasma (a) TG and (b) (V)LDL-C were determined. Values are means±s.e.m. (n=5–7 per group). *P<0.05 (unpaired two-tailed Student’s t-test).
